Background. The existence of a national renal biopsy register and a nationa
l terminal uraemia status register in Denmark provides an opportunity to st
udy the prognosis of glomerulonephritis (GN), and factors influencing progn
osis. Methods. Multivariate analysis of 2380 renal biopsies with GN perform
ed between 1985 and 1997 was done to determine the influence of clinical an
d histological factors on prognosis. Results. The incidence of GN (39/mio/y
ear) and individual diagnoses did not change during the period. After 10 ye
ars, 32% were dead, 13% terminally uraemic, 5% uraemic and 50% well. Older
age increased mortality, but not the incidence of renal failure after the f
irst year. Male sex increased both mortality and incidence of renal failure
(34 vs 24% at 10 years, P < 0.001). The diagnoses could be divided into th
ree prognostic groups compared with the general population: a good prognost
ic group (minimal change GN and membranous GN), with a relative mortality o
f three and a combined renal and patient mortality of four; a poor prognost
ic group [crescentic GN, HUS/TTP, chronic GN] with relative mortalities of
8-19 and 13-33, respectively; and the remainder with mortalities of 4-7 and
6-12. The presence of multiple glomerular pathology, chronic GN, nephroscl
erosis and chronic interstitial nephropathy worsened the prognosis, while t
he presence of immune deposits only worsened the prognosis of focal segment
al glomerulopathy. Mortality was related to uraemia and co-morbidity at bio
psy, and to the incidence of renal failure. Renal failure was correlated to
uraemia and hypertension at biopsy but not to nephrotic syndrome or athero
sclerosis. All vascular complications were increased and were positively re
lated to hypertension and negatively correlated to the incidence of uraemia
. Crescentric glomerulonephritis combined with anti-GEM disease had a worse
prognosis than Wegener's granulomatosis, with microscopic polyangiitis and
pauci-immune disease occupying an intermediate position. The prognosis of
mesangioproliferative GN was unaffected by the presence of IgA nephropathy
and systemic lupus erythematosus.